SGK1 and benign prostatic hyperplasia: According to the results of this study, SGK1 and ENPP1 are the biomarkers of Shenhailong formula in the treatment of BPH, and are enriched in multiple pathways, such as KRAS_SIGNALING_DN, ESTROGEN_RESPONSE_EARLY, and ESTROGEN_RESPONSE_LATE.